Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
2seventy bio
TSVT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.85
-0.2
-3.96%
Last update: 2:49 PM
15 minutes delayed
Get Report
Comment
2seventy bio (TSVT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for 2seventy bio (NASDAQ:TSVT) Stock
2seventy bio Stock (NASDAQ: TSVT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 07, 2024
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk
2seventy bio Q2 2024 Adj. EPS $(0.29) Beats $...
Benzinga Newsdesk
Monday, July 29, 2024
Morgan Stanley Maintains Equal-Weight on 2sev...
Benzinga Newsdesk
Thursday, June 27, 2024
Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
Vandana Singh
Wedbush Reiterates Neutral on 2seventy bio, M...
Benzinga Newsdesk
Wednesday, June 26, 2024
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk
2seventy Bio Sells Hemophilia A Candidate And...
Benzinga Newsdesk
Thursday, May 09, 2024
Canaccord Genuity Maintains Buy on 2seventy b...
Benzinga Newsdesk
Wednesday, May 08, 2024
2seventy bio Q1 Adj $(0.81), Inline, Sales $1...
Benzinga Newsdesk
Friday, April 19, 2024
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Vandana Singh
Tuesday, April 09, 2024
2Seventy Bio Said Co, Bristol Myers Squibb An...
Charles Gross
Monday, April 08, 2024
Citigroup Maintains Buy on 2seventy bio, Rais...
Benzinga Newsdesk
Friday, April 05, 2024
FDA Approves Bristol-Myers/2seventy Bio's Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer
Vandana Singh
At An Estimated Median Duration Of Follow-Up ...
Benzinga Newsdesk
U.S. FDA Approves Bristol Myers Squibb And 2s...
Benzinga Newsdesk
Wednesday, March 20, 2024
2seventy bio Adds Eli Casdin And Charles Newt...
Benzinga Newsdesk
Monday, March 18, 2024
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Vandana Singh
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Market-Moving News for March 18th
Benzinga Newsdesk
Wedbush Reiterates Neutral on 2seventy bio, M...
Benzinga Newsdesk
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk
Reported Saturday, FDA Advisory Committee Vot...
Benzinga Newsdesk
Friday, March 15, 2024
Trading Halt: Halt status updated at 6:55:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 1:00:00 p.m. ET - Tra...
Benzinga Newsdesk
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, March 07, 2024
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
Vandana Singh
Tuesday, March 05, 2024
2seventy bio Q4 EPS $(1.11) Misses $(0.99) Es...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
A Preview Of 2seventy bio's Earnings
Benzinga Insights
Monday, February 05, 2024
The FDA's Oncologic Drugs Advisory Committee ...
Benzinga Newsdesk
Friday, February 02, 2024
Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today?
Vandana Singh
Wednesday, January 31, 2024
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
Avi Kapoor
Leerink Partners Upgrades 2seventy bio to Out...
Benzinga Newsdesk
TD Cowen Downgrades 2seventy bio to Market Pe...
Benzinga Newsdesk
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk
2Seventy Bio Board Named William D. Baird, Ii...
Charles Gross
2Seventy Bio Announced That It Will Reduce It...
Charles Gross
2seventy bio Says, In Partnership With Bristo...
Benzinga Newsdesk
2seventy bio Names Chip Baird, Its COO, To Be...
Benzinga Newsdesk
2seventy To Focus Exclusively On Commercializ...
Benzinga Newsdesk
2seventy bio Reveals New Strategic Path Forwa...
Benzinga Newsdesk
Tuesday, January 23, 2024
FDA Reported Monday It Is Requiring Boxed Warning For CAR-T Cancer Therapies
Charles Gross
Tuesday, January 02, 2024
JW Therapeutics Announces Exclusive Collabora...
Benzinga Newsdesk
Tuesday, December 19, 2023
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
Piero Cingari
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch